UBP-1212

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameUBP-1212
Drug Alias NameUBP-1212
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsWet age-related macular degenerationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesShanghai Zhonghe Medicine Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Zhonghe Medicine Technology Co Ltd
Active IndicationsN/A
Inactive IndicationsWet age-related macular degenerationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A